Table 3 Univariable Cox regression for all patients (intermediate and high-risk)
Parameter | Risk | HR | 95% CI | p value |
|---|---|---|---|---|
BCR | ||||
PSMA-TV | > 7.8 ml | 0.17 | 0.02–1.26 | 0.083 |
PSMA-TLU | > 33.6 ml | 0.48 | 0.19–1.17 | 0.1 |
SUVmax | > 8.6 | 1.63 | 0.64–4.17 | 0.31 |
ASP | > 7.22% | 0.42 | 0.18–0.98 | 0.046 |
OS | ||||
PSMA-TV | > 14.9 ml | 34 | 3.7–312.7 | 0.002 |
PSMA-TLU | > 76 ml | 9.58 | 1.07–85.74 | 0.043 |
SUVmax | > 8.6 | 1.91 | 0.21–17.14 | 0.56 |
ASP | > 31.9% | 19.9 | 2.22–178.41 | 0.0075 |
LRC | ||||
PSMA-TV | > 1.48 ml | 4.84 | 0.62–37.58 | 0.13 |
PSMA-TLU | > 112 ml | 2.85 | 0.87–9.29 | 0.083 |
SUVmax | > 8.6 | 3.26 | 0.72–14.74 | 0.12 |
ASP | > 7.22% | 0.45 | 0.15–1.34 | 0.15 |
LC | ||||
PSMA-TV | > 4 ml | 0.21 | 0.03–1.7 | 0.14 |
PSMA-TLU | > 30.3 ml | 0.13 | 0.02–1.04 | 0.054 |
SUVmax | > 8.6 | 1.66 | 0.33–8.22 | 0.54 |
ASP | > 6.89% | 0.29 | 0.07–1.2 | 0.088 |